Systematic review and meta-analysis of the effects of menopause hormone therapy on risk of Alzheimer’s disease and dementia
IntroductionDespite a large preclinical literature demonstrating neuroprotective effects of estrogen, use of menopausal hormone therapy (HT) for Alzheimer’s disease (AD) risk reduction has been controversial. Herein, we conducted a systematic review and meta-analysis of HT effects on AD and dementia...
Main Authors: | Matilde Nerattini, Steven Jett, Caroline Andy, Caroline Carlton, Camila Zarate, Camila Boneu, Michael Battista, Silky Pahlajani, Susan Loeb-Zeitlin, Yelena Havryulik, Schantel Williams, Paul Christos, Matthew Fink, Roberta Diaz Brinton, Lisa Mosconi |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2023-10-01
|
Series: | Frontiers in Aging Neuroscience |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fnagi.2023.1260427/full |
Similar Items
-
Systematic review and meta-analysis of the effects of menopause hormone therapy on cognition
by: Caroline Andy, et al.
Published: (2024-03-01) -
Elevated gonadotropin levels are associated with increased biomarker risk of Alzheimer's disease in midlife women
by: Matilde Nerattini, et al.
Published: (2023-11-01) -
Sex-specific associations of serum cortisol with brain biomarkers of Alzheimer’s risk
by: Lisa Mosconi, et al.
Published: (2024-03-01) -
Sex-specific associations of serum testosterone with gray matter volume and cerebral blood flow in midlife individuals at risk for Alzheimer's disease.
by: Matilde Nerattini, et al.
Published: (2025-01-01) -
In vivo brain estrogen receptor density by neuroendocrine aging and relationships with cognition and symptomatology
by: Lisa Mosconi, et al.
Published: (2024-06-01)